Article
Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test.
Biogerontology - 1 Dec 2008
Kulkarni Amod P, Pillay Nirvana S, Kellaway Lauriston A, Kotwal Girish J
Abstract excerpt
One of the key pro-inflammatory mediators activated by amyloid protein in neurodegenerative disorders of the brain, such as Alzheimer's disease is the complement system. Vaccinia virus complement control protein secreted by vaccinia virus, commonly known as VCP, was found to inhibit amyloid protein mediated up-regulation of complement system in vitro. In the current research investigation, VCP was administered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
